Comaparing intravenous unfractionated heparin and hydro cortisone in prevention of thrombophlebitis

A randomized controlled study to compare the efficacy of intravenous unfractionated heparin versus intravenous hydrocortisone in prevention of thrombophlebitis. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063031

Enrollment

165

Registered

2024-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I808- Phlebitis and thrombophlebitis ofother sites

Interventions

Intervention1: Intravenous Hydrocortisone 12.5 mg: Route is Intravenous. Dose is Hydrocortisone 12.5 mg after applying pressure 2cm proximal from the tip of Intravenous cannula, for a duration of 30 s

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex 2. Age 18 to 65 yrs 3. American Society of Anaesthesiologists (ASA) physical status I & II.

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. ASA physical status III & IV 3. Pregnant women 4. Intellectually challenged patients 5. Patients with a known history of allergy to heparin 6. Patients undergoing general anaesthesia 7. Patients on anticoagulants or bleeding diathesis.

Design outcomes

Primary

Measure	Time frame
Reduction in incidence of thrombophlebitisTimepoint: 48 hrs	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDr R Gopinath

ESIC medical college and hospital,sanath nagar

gopi59@hotmail.com9848024306

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026